Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

125 trials with published results (16%)

Research Maturity

397 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.4%

49 terminated out of 766 trials

Success Rate

89.0%

+2.5% vs benchmark

Late-Stage Pipeline

10%

75 trials in Phase 3/4

Results Transparency

31%

125 of 397 completed with results

Key Signals

125 with results89% success49 terminated

Data Visualizations

Phase Distribution

537Total
Not Applicable (361)
Early P 1 (12)
P 1 (40)
P 2 (49)
P 3 (22)
P 4 (53)

Trial Status

Completed397
Unknown147
Recruiting86
Terminated49
Not Yet Recruiting29
Active Not Recruiting26

Trial Success Rate

89.0%

Benchmark: 86.5%

Based on 397 completed trials

Clinical Trials (766)

Showing 20 of 20 trials
NCT03941314Not ApplicableCompletedPrimary

A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease

NCT02264288Phase 2TerminatedPrimary

Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.

NCT03884257Not ApplicableActive Not RecruitingPrimary

A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.

NCT04349657Not ApplicableActive Not RecruitingPrimary

A Study Evaluating the Endovascular Treatment of Subjects With Stenotic or Restenotic Lesions of the Common Femoral Artery With the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy

NCT06186505Not ApplicableWithdrawnPrimary

Heat Therapy for Peripheral Arterial Disease (HEATPAD)

NCT07385573Not ApplicableNot Yet Recruiting

A Single Arm Trial to Evaluate the Safety and Efficacy of the Long (> 150mm) PasseoTM-18 LuxTM Drug-coated Balloon in the Treatment of Subjects With Infrainguinal Stenotic, Restenotic or Occlusive Lesions

NCT05058456Not ApplicableCompletedPrimary

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

NCT07335341Recruiting

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

NCT07619885Phase 1Recruiting

The Pharmacokinetics and Pharmacodynamics Study of CG-0255 Besylate and Plavix® in Healthy Participants

NCT04560998Phase 3Completed

A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

NCT06321575Not ApplicableRecruitingPrimary

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

NCT07144150Not ApplicableRecruiting

EVERO Drug-coated Balloon (DCB) Randomized Trial

NCT07223593Phase 3RecruitingPrimary

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

NCT01859117Phase 1CompletedPrimary

Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers

NCT07622485Not ApplicableNot Yet Recruiting

In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)

NCT03419325Early Phase 1Completed

A Genomic Approach for Clopidogrel in Caribbean Hispanics

NCT05358353Not ApplicableCompletedPrimary

A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)

NCT07614386Recruiting

Radial Access Data in Vascular Interventions Registry

NCT05992896Phase 4TerminatedPrimary

A Study of Loco-Regional Liposomal Bupivacaine Injection

NCT07336381Not ApplicableNot Yet RecruitingPrimary

Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy

Scroll to load more

Research Network

Activity Timeline